UroGen Pharma Ltd. - Ordinary Shares (URGN): Price and Financial Metrics

UroGen Pharma Ltd. - Ordinary Shares (URGN): $11.45

0.29 (+2.60%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add URGN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#96 of 332

in industry

URGN Price/Volume Stats

Current price $11.45 52-week high $20.70
Prev. close $11.16 52-week low $10.60
Day low $10.86 Volume 431,800
Day high $11.48 Avg. volume 500,654
50-day MA $12.45 Dividend yield N/A
200-day MA $14.59 Market Cap 268.55M

URGN Stock Price Chart Interactive Chart >


UroGen Pharma Ltd. - Ordinary Shares (URGN) Company Bio


UroGen Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing therapies for urological pathologies. The company is developing its product candidates as chemoablation agents, which are designed to remove tumors by non-surgical means, to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial carcinoma, and low-grade bladder cancer. The company was founded in 2004 and is based in Raanana, Israel.


URGN Latest News Stream


Event/Time News Detail
Loading, please wait...

URGN Latest Social Stream


Loading social stream, please wait...

View Full URGN Social Stream

URGN Price Returns

1-mo -8.18%
3-mo -19.14%
6-mo -13.52%
1-year -8.62%
3-year -6.83%
5-year -61.32%
YTD -23.67%
2023 69.11%
2022 -6.73%
2021 -47.23%
2020 -46.00%
2019 -22.50%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!